Philips completed the acquisition of BioTelemetry for $2.8bn.

Philips completed the acquisition of BioTelemetry, the remote medical technology company, for $2.8bn. “The acquisition of BioTelemetry fits perfectly with our strategy to be a leading provider of patient care management solutions for the hospital and the home. BioTelemetry’s leadership in the large and fast growing ambulatory cardiac diagnostics and monitoring market complements our leading position in the hospital. Leveraging our collective expertise, we will be in an optimal position to improve patient care across care settings for multiple diseases and medical conditions,” Frans van Houten, Philips CEO.